John Andreadis

John Andreadis is Founder and Managing Partner of Evolution Venture Partners and Founder and Member of the Board of Directors of Reset Pharmaceuticals. Mr. Andreadis has 25 years of experience in the investment banking and asset management business and has been instrumental in structuring over $1 billion dollar in strategic transactions and financings for domestic and international biotech and pharmaceutical companies. Prior to Founding Evolution Venture Partners, he was Founder and Managing Partner of HealthPro BioVentures which provided advisory services including strategic partnering, M&A advisory, and capital formation to the life sciences industry. Mr. Andreadis was the Founder and Managing Director of BlueStone Capital Partners that grew to more than 600 employees in five years. Mr. Andreadis began his career at Lehman Brothers in 1988 as a Financial Consultant. Mr. Andreadis attended Columbia University.